1099644-42-4
1099644-42-4 结构式
基本信息
4-([1,1'-联苯]-4-基)-2,7,7-三甲基-5-氧代-1,4,5,6,7,8-六氢喹啉-3-羧酸乙酯
CS-1731
AOB6123
SCHEMBL3239096
ITD1
ITD-1
ITD 1
ETHYL 4-{[1,1'-BIPHENYL]-4-YL}-2,7,7-TRIMETHYL-5-OXO-1,4,6,8-TETRAHYDROQUINOLINE-3-CARBOXYLATE
4-[1,1'-Biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-3-quinolinecarboxylic acid ethyl ester
3-Quinolinecarboxylic acid, 4-[1,1'-biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-, ethyl ester
物理化学性质
制备方法
141-97-9
126-81-8
3218-36-8
1099644-42-4
以对苯基苯甲醛(1 mmol)、5,5-二甲基-1,3-环己二酮(0.14 g,1 mmol)、乙酰乙酸乙酯(0.13 g,1 mmol)、乙酸铵(0.115 g,1.5 mmol)和Fe2O3(催化量)负载于羟基磷灰石(HAP,催化量)上为原料,加入三聚氰胺(0.15 g)作为助剂,在80℃下加热反应。反应进程通过薄层色谱(TLC,展开剂为正己烷/乙酸乙酯,体积比10:3)进行监测。反应完成后,将反应混合物冷却至室温,用热乙酸乙酯洗涤,并通过磁力分离去除催化剂。将固体残余物分离,并通过在热乙醇中重结晶进行纯化,得到目标产物4-([1,1'-联苯]-4-基)-2,7,7-三甲基-5-氧代-1,4,5,6,7,8-六氢喹啉-3-羧酸乙酯。
参考文献:
[1] RSC Advances, 2014, vol. 4, # 101, p. 57662 - 57670
[2] Research on Chemical Intermediates, 2015, vol. 41, # 10, p. 7227 - 7244
[3] Applied Organometallic Chemistry, 2016, vol. 30, # 5, p. 311 - 317
[4] Journal of Coordination Chemistry, 2017, vol. 70, # 2, p. 340 - 360
[5] Synthetic Communications, 2017, vol. 47, # 12, p. 1185 - 1191
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-12704 | ITD-1 | 1099644-42-4 | 1 mg | 360元 |
| 2025/12/22 | HY-12704 | ITD 1 ITD-1 | 1099644-42-4 | 5mg | 700元 |
| 2025/12/22 | HY-12704 | ITD 1 ITD-1 | 1099644-42-4 | 10mM * 1mLin DMSO | 770元 |
常见问题列表
| Target | Value |
|
TGF-β
() |
ITD-1 potently blocks phosphorylation of the effector SMAD2/3 proteins induced by TGFβ2, and only minimally in response to Activin A. HEK293T cells are transfected with a Smad4 response element driving luciferase (SBE4-Luc) to test whether ITD-1 blocks Activin A/Nodal and/or TGFβ signaling, which utilize the same intracellular signaling cascade through Smad4. ITD-1 strongly inhibits TGFβ2 signaling with similar efficacy (92% vs. 99% respectively), but with lower potency compared to SB-431542, an ACVR1B/TGFBR1 kinase inhibitor (IC 50 = 850nM vs. 70nM respectively), and is a weak and partial inhibitor of Activin A signals. ITD-1 selectively enhances the differentiation of uncommitted mesoderm to cardiomyocytes, but not to vascular smooth muscle and endothelial cells. ITD-1 reveals an unexpected role for TGFβ signaling in controlling cardiomyocyte differentiation from multipotent cardiovascular precursors .

